Completed NA INTERVENTIONAL 2-arm NCT02690792

Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease

Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease

Sponsor: Jeffrey Browning

Conditions Healthy NAFLD (Non-Alcoholic Fatty Liver Disease) NASH (Non-Alcoholic Steatohepatitis)

Interventions NAFLD/NASH - Placebo NAFLD/NASH - Vitamin E

Updated 7 times since 2017 Last updated: Nov 14, 2018 Started: Dec 31, 2009 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02690792, this NA trial focuses on Healthy and NAFLD (Non-Alcoholic Fatty Liver Disease) and remains completed. Sponsored by Jeffrey Browning, it has been updated 7 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2018 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jeffrey Browning
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States